Product
Nucleoside Reverse Transcriptase Inhibitors
1 clinical trial
1 indication
Indication
HIV InfectionsClinical trial
A Study of Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) to Maintain Viral Suppression in Adults Living With HIV-1Status: Completed, Estimated PCD: 2024-04-29